Global

Infectious Diseases Experts

Matthew Lorenzi


Vice President, Lung Cancer Disease
DIS Private Enterprise
Greece

Biography

Vice President, Lung Cancer Disease Collaborate with a talented research and development group focused on small molecule and biologics-based oncology drug discovery for lung cancer and other malignancies. Our team is delivering innovative next generation cancer immunotherapies and targeted agents to patients in dire need of new therapies.  Productive pharmaceutical experience in: -Establishing an R&D strategy and delivering an innovative portfolio against it -Strong productive people management and matrix management experience -Biologic & small molecule program generation and clinical advancement -Translational research experience to drive new combination and patient selection strategies -Search, evaluation & diligence of external biotech opportunities and pharma partnerships -Implementation of pre-clinical & clinical academic collaborations -Identification & execution of oncology strategic initiatives -Clinical development lead experience for biologic & small molecule agents for Phase I/II trials

Research Interest

Collaborate with a talented research and development group focused on small molecule and biologics-based oncology drug discovery for lung cancer and other malignancies. Our team is delivering innovative next generation cancer immunotherapies and targeted agents to patients in dire need of new therapies.  Productive pharmaceutical experience in: -Establishing an R&D strategy and delivering an innovative portfolio against it -Strong productive people management and matrix management experience -Biologic & small molecule program generation and clinical advancement -Translational research experience to drive new combination and patient selection strategies -Search, evaluation & diligence of external biotech opportunities and pharma partnerships -Implementation of pre-clinical & clinical academic collaborations -Identification & execution of oncology strategic initiatives -Clinical development lead experience for biologic & small molecule agents for Phase I/II trials

Global Experts from Greece

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America